Cargando…

Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites

Cardiac hypertrophic signaling cascades resulting in heart failure diseases are mediated by protein phosphorylation. Recent developments in mass spectrometry-based phosphoproteomics have led to the identification of thousands of differentially phosphorylated proteins and their phosphorylation sites....

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Hye Kyeong, Choi, Hyunwoo, Park, Sung-Gyoo, Park, Woo Jin, Kim,, Do Han, Park, Zee-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334354/
https://www.ncbi.nlm.nih.gov/pubmed/34158421
http://dx.doi.org/10.14348/molcells.2021.4002
_version_ 1783733051563442176
author Kwon, Hye Kyeong
Choi, Hyunwoo
Park, Sung-Gyoo
Park, Woo Jin
Kim,, Do Han
Park, Zee-Yong
author_facet Kwon, Hye Kyeong
Choi, Hyunwoo
Park, Sung-Gyoo
Park, Woo Jin
Kim,, Do Han
Park, Zee-Yong
author_sort Kwon, Hye Kyeong
collection PubMed
description Cardiac hypertrophic signaling cascades resulting in heart failure diseases are mediated by protein phosphorylation. Recent developments in mass spectrometry-based phosphoproteomics have led to the identification of thousands of differentially phosphorylated proteins and their phosphorylation sites. However, functional studies of these differentially phosphorylated proteins have not been conducted in a large-scale or high-throughput manner due to a lack of methods capable of revealing the functional relevance of each phosphorylation site. In this study, an integrated approach combining quantitative phosphoproteomics and cell-based functional screening using phosphorylation competition peptides was developed. A pathological cardiac hypertrophy model, junctate-1 transgenic mice and control mice, were analyzed using label-free quantitative phosphoproteomics to identify differentially phosphorylated proteins and sites. A cell-based functional assay system measuring hypertrophic cell growth of neonatal rat ventricle cardiomyocytes (NRVMs) following phenylephrine treatment was applied, and changes in phosphorylation of individual differentially phosphorylated sites were induced by incorporation of phosphorylation competition peptides conjugated with cell-penetrating peptides. Cell-based functional screening against 18 selected phosphorylation sites identified three phosphorylation sites (Ser-98, Ser-179 of Ldb3, and Ser-1146 of palladin) displaying near-complete inhibition of cardiac hypertrophic growth of NRVMs. Changes in phosphorylation levels of Ser-98 and Ser-179 in Ldb3 were further confirmed in NRVMs and other pathological/physiological hypertrophy models, including transverse aortic constriction and swimming models, using site-specific phospho-antibodies. Our integrated approach can be used to identify functionally important phosphorylation sites among differentially phosphorylated sites, and unlike conventional approaches, it is easily applicable for large-scale and/or high-throughput analyses.
format Online
Article
Text
id pubmed-8334354
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society for Molecular and Cellular Biology
record_format MEDLINE/PubMed
spelling pubmed-83343542021-08-11 Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites Kwon, Hye Kyeong Choi, Hyunwoo Park, Sung-Gyoo Park, Woo Jin Kim,, Do Han Park, Zee-Yong Mol Cells Research Article Cardiac hypertrophic signaling cascades resulting in heart failure diseases are mediated by protein phosphorylation. Recent developments in mass spectrometry-based phosphoproteomics have led to the identification of thousands of differentially phosphorylated proteins and their phosphorylation sites. However, functional studies of these differentially phosphorylated proteins have not been conducted in a large-scale or high-throughput manner due to a lack of methods capable of revealing the functional relevance of each phosphorylation site. In this study, an integrated approach combining quantitative phosphoproteomics and cell-based functional screening using phosphorylation competition peptides was developed. A pathological cardiac hypertrophy model, junctate-1 transgenic mice and control mice, were analyzed using label-free quantitative phosphoproteomics to identify differentially phosphorylated proteins and sites. A cell-based functional assay system measuring hypertrophic cell growth of neonatal rat ventricle cardiomyocytes (NRVMs) following phenylephrine treatment was applied, and changes in phosphorylation of individual differentially phosphorylated sites were induced by incorporation of phosphorylation competition peptides conjugated with cell-penetrating peptides. Cell-based functional screening against 18 selected phosphorylation sites identified three phosphorylation sites (Ser-98, Ser-179 of Ldb3, and Ser-1146 of palladin) displaying near-complete inhibition of cardiac hypertrophic growth of NRVMs. Changes in phosphorylation levels of Ser-98 and Ser-179 in Ldb3 were further confirmed in NRVMs and other pathological/physiological hypertrophy models, including transverse aortic constriction and swimming models, using site-specific phospho-antibodies. Our integrated approach can be used to identify functionally important phosphorylation sites among differentially phosphorylated sites, and unlike conventional approaches, it is easily applicable for large-scale and/or high-throughput analyses. Korean Society for Molecular and Cellular Biology 2021-07-31 2021-06-23 /pmc/articles/PMC8334354/ /pubmed/34158421 http://dx.doi.org/10.14348/molcells.2021.4002 Text en © The Korean Society for Molecular and Cellular Biology. All rights reserved. https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ (https://creativecommons.org/licenses/by-nc-sa/3.0/)
spellingShingle Research Article
Kwon, Hye Kyeong
Choi, Hyunwoo
Park, Sung-Gyoo
Park, Woo Jin
Kim,, Do Han
Park, Zee-Yong
Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites
title Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites
title_full Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites
title_fullStr Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites
title_full_unstemmed Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites
title_short Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites
title_sort integrated quantitative phosphoproteomics and cell-based functional screening reveals specific pathological cardiac hypertrophy-related phosphorylation sites
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334354/
https://www.ncbi.nlm.nih.gov/pubmed/34158421
http://dx.doi.org/10.14348/molcells.2021.4002
work_keys_str_mv AT kwonhyekyeong integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites
AT choihyunwoo integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites
AT parksunggyoo integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites
AT parkwoojin integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites
AT kimdohan integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites
AT parkzeeyong integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites